Package 50090-7712-0

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 50090-7712-0
Digits Only 5009077120
Product NDC 50090-7712
Product ID 50090-7712_359611d3-5a52-4b41-8c6b-9763ae49cbd3
Description

90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7712-0)

Marketing

Marketing Status
Marketed Since 2025-10-14
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "359611d3-5a52-4b41-8c6b-9763ae49cbd3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["16ffe2ac-4f71-4843-99df-611f53c2f3cd"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7712-0)", "package_ndc": "50090-7712-0", "marketing_start_date": "20251014"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50090-7712_359611d3-5a52-4b41-8c6b-9763ae49cbd3", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7712", "generic_name": "Bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20231025", "listing_expiration_date": "20261231"}